COG4_HUMAN - dbPTM
COG4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID COG4_HUMAN
UniProt AC Q9H9E3
Protein Name Conserved oligomeric Golgi complex subunit 4
Gene Name COG4
Organism Homo sapiens (Human).
Sequence Length 785
Subcellular Localization Golgi apparatus membrane
Peripheral membrane protein
Cytoplasmic side .
Protein Description Required for normal Golgi function. Plays a role in SNARE-pin assembly and Golgi-to-ER retrograde transport via its interaction with SCFD1..
Protein Sequence MADLDSPPKLSGVQQPSEGVGGGRCSEISAELIRSLTELQELEAVYERLCGEEKVVERELDALLEQQNTIESKMVTLHRMGPNLQLIEGDAKQLAGMITFTCNLAENVSSKVRQLDLAKNRLYQAIQRADDILDLKFCMDGVQTALRSEDYEQAAAHTHRYLCLDKSVIELSRQGKEGSMIDANLKLLQEAEQRLKAIVAEKFAIATKEGDLPQVERFFKIFPLLGLHEEGLRKFSEYLCKQVASKAEENLLMVLGTDMSDRRAAVIFADTLTLLFEGIARIVETHQPIVETYYGPGRLYTLIKYLQVECDRQVEKVVDKFIKQRDYHQQFRHVQNNLMRNSTTEKIEPRELDPILTEVTLMNARSELYLRFLKKRISSDFEVGDSMASEEVKQEHQKCLDKLLNNCLLSCTMQELIGLYVTMEEYFMRETVNKAVALDTYEKGQLTSSMVDDVFYIVKKCIGRALSSSSIDCLCAMINLATTELESDFRDVLCNKLRMGFPATTFQDIQRGVTSAVNIMHSSLQQGKFDTKGIESTDEAKMSFLVTLNNVEVCSENISTLKKTLESDCTKLFSQGIGGEQAQAKFDSCLSDLAAVSNKFRDLLQEGLTELNSTAIKPQVQPWINSFFSVSHNIEEEEFNDYEANDPWVQQFILNLEQQMAEFKASLSPVIYDSLTGLMTSLVAVELEKVVLKSTFNRLGGLQFDKELRSLIAYLTTVTTWTIRDKFARLSQMATILNLERVTEILDYWGPNSGPLTWRLTPAEVRQVLALRIDFRSEDIKRLRL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MADLDSPPK
------CCCCCCCCC
26.5222814378
6Phosphorylation--MADLDSPPKLSGV
--CCCCCCCCCCCCC
50.8529255136
10PhosphorylationDLDSPPKLSGVQQPS
CCCCCCCCCCCCCCC
7.1219413330
11PhosphorylationLDSPPKLSGVQQPSE
CCCCCCCCCCCCCCC
42.9422167270
17PhosphorylationLSGVQQPSEGVGGGR
CCCCCCCCCCCCCCC
42.5225159151
21PhosphorylationQQPSEGVGGGRCSEI
CCCCCCCCCCCHHHH
43.6320058876
26PhosphorylationGVGGGRCSEISAELI
CCCCCCHHHHHHHHH
36.2825627689
37PhosphorylationAELIRSLTELQELEA
HHHHHHHHHHHHHHH
35.58-
46PhosphorylationLQELEAVYERLCGEE
HHHHHHHHHHHHCCH
11.4628796482
50PhosphorylationEAVYERLCGEEKVVE
HHHHHHHHCCHHHHH
8.9227642862
54AcetylationERLCGEEKVVERELD
HHHHCCHHHHHHHHH
47.4825953088
54UbiquitinationERLCGEEKVVERELD
HHHHCCHHHHHHHHH
47.48-
58UbiquitinationGEEKVVERELDALLE
CCHHHHHHHHHHHHH
37.86-
73 (in isoform 1)Ubiquitination-25.3021890473
73 (in isoform 2)Ubiquitination-25.3021890473
73UbiquitinationQQNTIESKMVTLHRM
HHCCHHHHHHHHHHC
25.3021890473
73UbiquitinationQQNTIESKMVTLHRM
HHCCHHHHHHHHHHC
25.3021890473
77UbiquitinationIESKMVTLHRMGPNL
HHHHHHHHHHCCCCC
1.32-
77 (in isoform 3)Ubiquitination-1.3221890473
99PhosphorylationKQLAGMITFTCNLAE
HHHHHHHHHHHCCHH
12.1929978859
101PhosphorylationLAGMITFTCNLAENV
HHHHHHHHHCCHHHH
7.5829978859
109PhosphorylationCNLAENVSSKVRQLD
HCCHHHHHHHHHHHH
35.7029978859
110PhosphorylationNLAENVSSKVRQLDL
CCHHHHHHHHHHHHH
30.7829978859
121MethylationQLDLAKNRLYQAIQR
HHHHHHHHHHHHHHH
33.78-
123PhosphorylationDLAKNRLYQAIQRAD
HHHHHHHHHHHHHHH
7.8328796482
123UbiquitinationDLAKNRLYQAIQRAD
HHHHHHHHHHHHHHH
7.83-
125MethylationAKNRLYQAIQRADDI
HHHHHHHHHHHHHHH
6.06-
127PhosphorylationNRLYQAIQRADDILD
HHHHHHHHHHHHHHC
37.2127642862
166UbiquitinationHRYLCLDKSVIELSR
CHHEEECHHHHHHHH
33.40-
170UbiquitinationCLDKSVIELSRQGKE
EECHHHHHHHHCCCC
38.24-
176 (in isoform 1)Ubiquitination-51.0321890473
176UbiquitinationIELSRQGKEGSMIDA
HHHHHCCCCCCCHHH
51.0321906983
176 (in isoform 2)Ubiquitination-51.0321890473
179PhosphorylationSRQGKEGSMIDANLK
HHCCCCCCCHHHHHH
17.4120363803
180UbiquitinationRQGKEGSMIDANLKL
HCCCCCCCHHHHHHH
4.77-
183PhosphorylationKEGSMIDANLKLLQE
CCCCCHHHHHHHHHH
16.60-
186UbiquitinationSMIDANLKLLQEAEQ
CCHHHHHHHHHHHHH
47.13-
190UbiquitinationANLKLLQEAEQRLKA
HHHHHHHHHHHHHHH
54.89-
200UbiquitinationQRLKAIVAEKFAIAT
HHHHHHHHHHHHHHC
14.24-
207PhosphorylationAEKFAIATKEGDLPQ
HHHHHHHCCCCCCHH
24.4220860994
208UbiquitinationEKFAIATKEGDLPQV
HHHHHHCCCCCCHHH
51.1621906983
208 (in isoform 2)Ubiquitination-51.1621890473
208 (in isoform 1)Ubiquitination-51.1621890473
211PhosphorylationAIATKEGDLPQVERF
HHHCCCCCCHHHHHH
57.1624719451
212UbiquitinationIATKEGDLPQVERFF
HHCCCCCCHHHHHHH
4.74-
234UbiquitinationLHEEGLRKFSEYLCK
CCHHHHHHHHHHHHH
59.28-
238UbiquitinationGLRKFSEYLCKQVAS
HHHHHHHHHHHHHHH
19.05-
245UbiquitinationYLCKQVASKAEENLL
HHHHHHHHHHHHCHH
33.28-
260PhosphorylationMVLGTDMSDRRAAVI
HHHCCCCCHHHHHHH
30.6725332170
320UbiquitinationQVEKVVDKFIKQRDY
HHHHHHHHHHHCCHH
37.06-
323UbiquitinationKVVDKFIKQRDYHQQ
HHHHHHHHCCHHHHH
42.27-
324UbiquitinationVVDKFIKQRDYHQQF
HHHHHHHCCHHHHHH
38.37-
327UbiquitinationKFIKQRDYHQQFRHV
HHHHCCHHHHHHHHH
12.06-
346 (in isoform 1)Ubiquitination-50.7221890473
346UbiquitinationMRNSTTEKIEPRELD
HCCCCCCCCCHHHCC
50.7221906983
350UbiquitinationTTEKIEPRELDPILT
CCCCCCHHHCCHHHH
44.30-
378PhosphorylationRFLKKRISSDFEVGD
HHHHHHCCCCCCCCC
28.08-
379PhosphorylationFLKKRISSDFEVGDS
HHHHHCCCCCCCCCC
43.9028258704
382PhosphorylationKRISSDFEVGDSMAS
HHCCCCCCCCCCCCC
51.05-
383PhosphorylationRISSDFEVGDSMASE
HCCCCCCCCCCCCCH
11.87-
393UbiquitinationSMASEEVKQEHQKCL
CCCCHHHHHHHHHHH
53.93-
397UbiquitinationEEVKQEHQKCLDKLL
HHHHHHHHHHHHHHH
37.09-
443AcetylationVALDTYEKGQLTSSM
HHCCCCCCCCCCHHH
41.3619608861
447AcetylationTYEKGQLTSSMVDDV
CCCCCCCCHHHHHHH
15.7419608861
447PhosphorylationTYEKGQLTSSMVDDV
CCCCCCCCHHHHHHH
15.7429978859
448PhosphorylationYEKGQLTSSMVDDVF
CCCCCCCHHHHHHHH
25.6529978859
449PhosphorylationEKGQLTSSMVDDVFY
CCCCCCHHHHHHHHH
20.0029978859
456PhosphorylationSMVDDVFYIVKKCIG
HHHHHHHHHHHHHHH
12.4929978859
514PhosphorylationQDIQRGVTSAVNIMH
HHHHHCHHHHHHHHH
17.5025693802
515PhosphorylationDIQRGVTSAVNIMHS
HHHHCHHHHHHHHHH
28.0125693802
519PhosphorylationGVTSAVNIMHSSLQQ
CHHHHHHHHHHHHHC
1.8027251275
522PhosphorylationSAVNIMHSSLQQGKF
HHHHHHHHHHHCCCC
18.5028857561
523PhosphorylationAVNIMHSSLQQGKFD
HHHHHHHHHHCCCCC
18.6028348404
527PhosphorylationMHSSLQQGKFDTKGI
HHHHHHCCCCCCCCC
21.4527251275
532UbiquitinationQQGKFDTKGIESTDE
HCCCCCCCCCCCCHH
60.792190698
532AcetylationQQGKFDTKGIESTDE
HCCCCCCCCCCCCHH
60.797697129
532 (in isoform 1)Ubiquitination-60.7921890473
536UbiquitinationFDTKGIESTDEAKMS
CCCCCCCCCHHHHHE
38.96-
571UbiquitinationTLESDCTKLFSQGIG
HHHHHHHHHHHCCCC
54.59-
575UbiquitinationDCTKLFSQGIGGEQA
HHHHHHHCCCCHHHH
39.94-
588PhosphorylationQAQAKFDSCLSDLAA
HHHHHHHHHHHHHHH
21.79-
589UbiquitinationAQAKFDSCLSDLAAV
HHHHHHHHHHHHHHH
4.55-
591PhosphorylationAKFDSCLSDLAAVSN
HHHHHHHHHHHHHHH
34.60-
597PhosphorylationLSDLAAVSNKFRDLL
HHHHHHHHHHHHHHH
29.58-
672PhosphorylationASLSPVIYDSLTGLM
HHCCHHHHHHHHHHH
10.34-
697UbiquitinationVVLKSTFNRLGGLQF
HHHHHHHHHCCCCCC
38.05-
706UbiquitinationLGGLQFDKELRSLIA
CCCCCCCHHHHHHHH
60.99-
710PhosphorylationQFDKELRSLIAYLTT
CCCHHHHHHHHHHHH
36.4325954137
710UbiquitinationQFDKELRSLIAYLTT
CCCHHHHHHHHHHHH
36.43-
714PhosphorylationELRSLIAYLTTVTTW
HHHHHHHHHHHHHHH
9.5118083107
717PhosphorylationSLIAYLTTVTTWTIR
HHHHHHHHHHHHHHH
17.1725954137
718PhosphorylationLIAYLTTVTTWTIRD
HHHHHHHHHHHHHHH
3.6518083107
722PhosphorylationLTTVTTWTIRDKFAR
HHHHHHHHHHHHHHH
12.2125954137
753PhosphorylationLDYWGPNSGPLTWRL
HHHHCCCCCCCEEEC
44.9420860994

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of COG4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of COG4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of COG4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
COG1_HUMANCOG1physical
15047703
COG2_HUMANCOG2physical
15047703
COG5_HUMANCOG5physical
15047703
COG7_HUMANCOG7physical
15047703
COG7_HUMANCOG7physical
22939629
COG5_HUMANCOG5physical
22939629
COG8_HUMANCOG8physical
22939629
RS20_HUMANRPS20physical
22939629
COG1_HUMANCOG1physical
26344197
COG6_HUMANCOG6physical
26344197
COG7_HUMANCOG7physical
26344197

Drug and Disease Associations
Kegg Disease
H00119 Congenital disorders of glycosylation (CDG) type II
OMIM Disease
613489Congenital disorder of glycosylation 2J (CDG2J)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of COG4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-443, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6, AND MASS SPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-714, AND MASSSPECTROMETRY.

TOP